Want to join the conversation?
Drug and medical devices maker $MNK completes the acquisition of Therakos, Inc. for value of approx. $1.325Bil. $MNK expects FY15 net sales of $185-$195MM for Therakos products & high single-digit growth going forward. The transaction is accretive $0.10 per share to $MNK's adjusted diluted FY16 earnings & increasingly accretive thereafter.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th